Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome (Q46758158)
Jump to navigation
Jump to search
scientific article published on 13 October 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome |
scientific article published on 13 October 2005 |
Statements
1 reference
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome (English)
1 reference
1 reference
1 reference
Olivier Lortholary
1 reference
Thomas F Patterson
1 reference
John R Wingard
1 reference
Haran T Schlamm
1 reference
Helen W Boucher
1 reference
Patricia Ribaud
1 reference
Peter Troke
1 reference
Robert H Rubin
1 reference
Ben DePauw
1 reference
John E Bennett
1 reference
European Organization for Research and Treatment of Cancer (EORTC) Invasive Fungal Infections Group (IFIG)
1 reference
Pfizer Global Aspergillus Study Group
1 reference
13 October 2005
1 reference
1 reference
41
1 reference
10
1 reference
1448-1452
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference